Nanomedicine in cancer therapy: Advancing precision treatments

Authors

• Abdullahi Tunde Aborode, Mississippi State UniversityFollow
• Ayomide Samson Oluwajoba, Università Politecnica delle MarcheFollow
• Aminat Modupe Ibrahim, University of IlorinFollow
• Shahzaib Ahmad, King Edward Medical University LahoreFollow
• Aashna Mehta, Általános Orvostudományi KarFollow
• Osasere Jude Kelly Osayawe, Brigham Young UniversityFollow
• Damilola Oyebode, University of Southern MississippiFollow
• Oluwaseun Akinsola, Central Washington UniversityFollow
• Abraham Osinuga, University of Nebraska-LincolnFollow
• Isreal Ayobami Onifade, State University of New York AlbanyFollow
• Ibrahim O. Adelakun, State University of New York AlbanyFollow
• Ridwan Olamilekan Adesola, University of IbadanFollow
• Taiwo Bakare Abidola, Georgia Southern UniversityFollow
• Adedeji Daniel Ogunyemi, Nautilus BiotechnologyFollow
• Oluwaseun Adeolu Ogundijo, University of IbadanFollow
• Olamilekan Gabriel Banwo, University of IbadanFollow
• Chibuzo H. Obiechefu, University of Ibadan

Document Type

Article

Publication Date

1-1-2024

School

Biological, Environmental, and Earth Sciences

Abstract

The progress made in the field of nanotechnology has resulted in the development of nanomedicine agents, which have demonstrated their efficacy as a promising clinical tool in the fight against different types of cancers. Furthermore, Nanomedicine products possess the potential to achieve intricate targeting strategies and multifunctionality. Currently, nanoparticles possess diverse applications across various scientific disciplines and serve as a crucial component in contemporary medical practices. The specimens have undergone analysis for diverse clinical purposes, including serving as drug carriers, delivering tumor genes, and functioning as contrast compounds in imaging. Diverse nanomaterials derived from organic, inorganic, lipid, or glycan compounds, in addition to synthetic polymers, have been employed to advance and enhance novel cancer therapeutics. The present review centers on the utilization of nanoparticles in clinical settings for the purposes of cancer diagnosis and treatment, with a particular emphasis on their function as drug carriers and targeted therapy agents.

Publication Title

Advances in Biomarker Sciences and Technology

Volume

6

First Page

105

Last Page

119

Recommended Citation

Aborode, A., Oluwajoba, A., Ibrahim, A., Ahmad, S., Mehta, A., Osayawe, O., Oyebode, D., Akinsola, O., Osinuga, A., Onifade, I., Adelakun, I., Adesola, R., Abidola, T., Ogunyemi, A., Ogundijo, O., Banwo, O., Obiechefu, C. (2024). Nanomedicine in cancer therapy: Advancing precision treatments. Advances in Biomarker Sciences and Technology, 6, 105-119.
Available at: https://aquila.usm.edu/fac_pubs/22161